Controversial US-backed vaccine trial in African newborns halted

According to the report, a controversial hepatitis B vaccine trial involving newborns in Guinea-Bissau has been halted. The study, which was planned to be funded by the US CDC, faced significant global backlash. Frederik Schaltz-Buchholzer, a Danish researcher leading the project, stated on social media that the trial would not proceed in the country. He explained that the team did not receive the necessary governmental approval to continue. This development marks the end of the specific research initiative that had sparked widespread criticism prior to its suspension.

Source: The Guardian

This summary was written by AI from the information reported by the sources above and may contain errors. Check the sources for certainty.